A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)
Phase: PHASE2 | Sponsor: Sunstone Medical | Compound: Psilocybin
- Status
- recruiting
- Institution
- Sunstone Medical
- Start date
- 2025-12-01
- End date
- 2027-10-01
- Registry ID
- NCT06902974
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.